Stockscreener 앱 받기
10.14
0.00%
0.00
시간 외 거래:
10.14
전일 마감가:
$10.14
열려 있는:
$10.14
하루 거래량:
317
Relative Volume:
0.00
시가총액:
$645.92M
수익:
-
순이익/손실:
$8.58M
주가수익비율:
75.67
EPS:
0.134
순현금흐름:
$-1.11M
1주 성능:
+0.00%
1개월 성능:
+0.30%
6개월 성능:
+1.60%
1년 성능:
+0.00%
1일 변동 폭
$10.14
$10.14
1주일 범위
$10.12
$10.21
52주 변동 폭
$9.87
$10.21
Drugs Made In America Acquisition Ii Corp Stock (DMII) Company Profile
명칭
Drugs Made In America Acquisition Ii Corp
전화
954-870-3104
주소
420 LEXINGTON AVENUE, NEW YORK
Compare DMII vs LION, XXI, UMAC, CCXI, AAC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DMII
Drugs Made In America Acquisition Ii Corp
|
10.14 | 645.92M | 0 | 8.58M | -1.11M | 0.134 |
LION
Lionsgate Studios Corp
|
11.40 | 3.41B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
6.01 | 3.48B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
23.98 | 1.30B | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
13.97 | 783.70M | 0 | 0 | 0 | 0.0647 |
AAC
Ares Acquisition Corporation
|
10.06 | 761.82M | 0 | -10.01M | -1.23M | -0.08 |
Drugs Made In America Acquisition Ii Corp 주식(DMII)의 최신 뉴스
Drugs (DMII): Closes 0.20% Higher at $10.14 in Latest Trading; Chart Watch: $9.63 and $10.65 Define the Nearby Reference Levels in Latest TradingBuy Signal Reports - vinanet.vn
Drugs (DMII) Momentum: Ends Up by 0.10% at $10.13 in the Current Update; Current Setup: the Price Remains Bounded by the Supplied Support and Resistance in the Latest SessionMarket Neutral Pair - vinanet.vn
Drugs Made In America Acquisition Corp. (DMAA) Stock Price, Chart, News & Analysis - Securities.io
Drugs (DMIIR) Daily Review: Closes with Little Net Change at $0.10 in Latest Trading; Level-Based View: the Current Price Sits Inside the Supplied Technical Range at the CloseMerger Arbitrage - Vinanet
DMII Holds at $10.13: Drugs Made In America Acquisition II Corp. Trades Flat Amid SPAC Market ConsolidationAdvance Decline Volume - dars.gov.et
Drugs Made In America Acquisition II (DMII) Earnings Date and Reports 2026 - MarketBeat
DMII Holds Steady at $10.13 as Acquisition Vehicle Trades in Tight RangeGamma Exposure - Vinanet
Drugs Made In America II (DMII) earns $8.7M but warns on going concern - Stock Titan
Drugs Made In America Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Karpus Management (DMAA) discloses 10.33% beneficial stake in SPAC - Stock Titan
Drugs Made In America (DMAA): First Trust funds disclose 3.24% beneficial stake - Stock Titan
DMAA Holds at $10.69 as SPAC Awaits Definitive Acquisition TargetPCR Moving Average - vinanet.vn
Drugs Made In America Acquisition II Corp. (DMIIU) Holds Steady at $10.17 as SPAC Unit Trades in Tight RangeIchimoku Cloud - vinanet.vn
Glazer Capital (DMAA) discloses 4.12% beneficial stake in Drugs Made in America - Stock Titan
Mizuho Financial Group (DMAA) discloses 8.5% beneficial stake in SPAC - Stock Titan
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Encyclopedia Britannica
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
DMII Holds at $10.11: Drugs Made In America Acquisition II Shows Typical Pre-Deal StabilitySystematic Flow - Vinanet
Pfizer Inc. - Encyclopedia Britannica
Drugs Made In America Acquisition Corp (DMAA) Stock News Today - TradingKey
COPL|Copley Acquisition Corp|Price:10.480|Chg%:+0.010 - TradingKey
DMAAR Rights Edge Up to $0.16 as Tight Range Between Support and Resistance PersistsVolume Oscillator - Vinanet
DMII Holds Steady at $10.12 as SPAC Trades Near Trust ValueDealer Positioning - Vinanet
ICU Medical Inc. (ICUI) Gains 2.67%: Approaching Key Resistance LevelsStatistical Arbitrage - Vinanet
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
CAII|Collective Acquisition II Ord Shs Class A|Price:9.950|Chg%:+0.010 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.130|Chg%:+0.020 - TradingKey
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.140|Chg%:+0.040 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
UAC|United Acquisition I Units|Price:9.930|Chg%:-0.010 - TradingKey
ALUB|Alussa Energy Acquisition II Ord Shs Class A|Price:10.120|Chg%:+0.010 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Income Statement - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Balance Sheet - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BBCQ|Bleichroeder Acquisition II Units|Price:10.170| - TradingKey
HTB Q1 2026 Earnings: EPS Beats Estimates by Nearly 20% Amid Solid Operating PerformanceGuidance Update - vinanet.vn
QETA|Quetta Acquisition Corp|Price:11.430| - TradingKey
BLUW|Blue Water Acquisition Corp III|Price:10.340|Chg%:+0.010 - TradingKey
IRAB|Iris Acquisition II Units|Price:10.000|Chg%:+0.020 - TradingKey
PAII|Pyrophyte Acquisition Corp II|Price:10.240|Chg%:-0.010 - TradingKey
DRDB|Roman DBDR Acquisition Corp II|Price:10.585|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
Drugs Made In America Acquisition Ii Corp (DMII) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.05%
0.28%
자본화:
|
볼륨(24시간):